Crowdonomics
This isn’t CANCERVAX’s most recent raise. Reg CF · Common Stock · Jun 2026 (Open) is more current.View latest round
CANCERVAX

Private · Series B Preferred Stock · Oct 2023

ClosedOtherPreferred Equity
via the platform · last checked Oct 3, 2026
Raised
$500K
Investors
—
—
Estimated pre-money
$25.1M
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$25.1M
Price / share$100.00

Estimated, not stated: $100.00 × 251,125 as-converted securities outstanding as of Apr 26, 2023 (Form 1-A/A filed Apr 26, 2023).

Offering details

Target—
Max—
Min investment—
OpenedOct 1, 2023
Deadline—
ClosedOct 1, 2023
Days active1

Links & provenance

Source: SEC EDGAR
Last synced Oct 3, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.